Pharmaniaga inks local manufacturing deal with Sinovac Biotech


A health worker shows a vial of Sinovac Biotech’s Coronavac during the vaccination of Philippine military at the national headquarters of the Philippine Army in Fort Bonifacio, Taguig City, Metro Manila, Philippines, on Tuesday (March 2, 2021). - Reuters

KUALA LUMPUR: Pharmaniaga Bhd has signed a local manufacturing agreement with China's Sinovac Biotech Ltd's subsidiary for the purchase of ready-to-fill bulk product of Covid-19 vaccine.

The company said on Monday its unit Pharmaniaga Lifescience Sdn Bhd (PLS) and Sinovac Life Sciences Co. Ltd had entered into the agreement on March 12 for the manufacturing of the vaccine by PLS.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

ISF Group IPO oversubscribed by over 31 times
Corporate bond market set to hit RM130bil-RM140bil
ICT Zone wins RM17.3mil tech contract
PJBumi buys drilling rigs for RM162mil
Swift Energy unit bags contracts worth RM18mil
MyTech takeover bid turns unconditional�
Matrade: Malaysia’s trade breaks RM3 trillion mark despite challenging global conditions
Swift Energy Tech subsidiary bags contracts worth RM18mil
Reneuco redesignates Mustakim Mat Nun to group MD
ISF Group IPO oversubscribed by over 31 times

Others Also Read